Baker Bros. Advisors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $357K | Sell |
|
|||||
|
2021
Q1 | $5.16M | Hold |
|
|||||
|
2020
Q4 | $7.49M | Hold |
|
|||||
|
2020
Q3 | $6.1M | Hold |
|
|||||
|
2020
Q2 | $7.36M | Hold |
|
|||||
|
2020
Q1 | $4.09M | Hold |
|
|||||
|
2019
Q4 | $4.77M | Sell |
|
|||||
|
2019
Q3 | $10.1M | Hold |
|
|||||
|
2019
Q2 | $9.03M | Buy |
|
|||||
|
2019
Q1 | $5.25M | Hold |
|
|||||
|
2018
Q4 | $3.2M | Hold |
|
|||||
|
2018
Q3 | $6.85M | Hold |
|
|||||
|
2018
Q2 | $5.87M | Hold |
|
|||||
|
2018
Q1 | $7.46M | Hold |
|
|||||
|
2017
Q4 | $5.59M | Hold |
|
|||||
|
2017
Q3 | $8.46M | Hold |
|
|||||
|
2017
Q2 | $9.25M | Buy |
|
|||||
|
2017
Q1 | $3.26M | Hold |
|
|||||
|
2016
Q4 | $2.49M | Hold |
|
|||||
|
2016
Q3 | $2.84M | Hold |
|
|||||
|
2016
Q2 | $3.71M | Buy |
|